{"id":"W4400211491","doi":"10.1183/16000617.0015-2024","title":"Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis","year":2024,"lang":"en","type":"review","venue":"European Respiratory Review","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Lung Foundation Netherlands; Servier; Horizon Therapeutics; Argenx; Galecto; Galderma; Eli Lilly and Company; AstraZeneca; CSL Behring; Sanofi; ZonMw; Amgen; Pfizer; Glenmark Pharmaceuticals; Acceleron; Daiichi-Sankyo; United Therapeutics Corporation","keywords":"Lysophosphatidic acid; Autotaxin; Medicine; Idiopathic pulmonary fibrosis; Fibrosis; Clinical trial; Inflammation; Disease; Receptor; Lung; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003736301,0.0005908132,0.001150398,0.001447949,0.0001803663,0.0007239559,0.0006107535,0.001002594,0.004983863],"category_scores_gemma":[0.0004605212,0.0001644659,0.0006969227,0.0009812658,0.0001983316,0.0006809829,0.000439218,0.001490945,0.001932398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003136248,"about_ca_system_score_gemma":0.0007015116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004744143,"about_ca_topic_score_gemma":0.001225004,"domain_scores_codex":[0.9998626,0.00003187832,0.00002150416,0.00002184612,0.00004443824,0.00001783516],"domain_scores_gemma":[0.9998509,0.00006924086,0.00002625837,0.000003668441,0.00003682938,0.00001317913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002115411,0.0001125234,0.0001126945,0.03383183,0.0001959775,0.0002491684,0.00005126697,0.0003306557,0.003953392,0.002487652,0.02669763,0.9317657],"study_design_scores_gemma":[0.0001240433,0.0003509357,0.001255874,0.009401285,0.0004237661,0.001869731,0.00006585056,0.000152871,0.0011174,0.001497275,0.9837155,0.00002550253],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001688568,0.998827,0.00007464178,0.0001684514,0.0001517524,0.000005411592,0.00002005367,0.000006333505,0.0005775523],"genre_scores_gemma":[0.001103069,0.9978352,0.0001474373,0.0002279639,0.0001003946,0.000009000346,0.0000468769,0.000001575116,0.0005283949],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004983863,"threshold_uncertainty_score":0.01667273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05534831685234662,"score_gpt":0.3400771089941969,"score_spread":0.2847287921418503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}